From: Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
Patients, n | Multivariate HR (95% CI) | P value | |
---|---|---|---|
Age | |||
< 60 | 70 | 1.00 (ref) | |
60–74 | 176 | 1.70 (0.91–3.18) | 0.099 |
≥ 75 | 173 | 3.42 (1.84–6.34) | < 0.001 |
Stage | |||
I | 78 | 1.00 (ref) | |
II | 168 | 1.24 (0.66–2.34) | 0.498 |
III | 117 | 2.32 (1.24–4.34) | 0.009 |
IV | 56 | 11.10 (5.91–20.85) | < 0.001 |
ZNF331 methylation | |||
ZNF331 unmeth | 121 | 1.00 (ref) | |
ZNF331 meth | 298 | 1.44 (0.97–2.14) | 0.069 |